Persson, C. U., von Stedingk, K., Bexell, D., Merselius, M., Braekeveldt, N., Gisselsson, D., . . . Wigerup, C. (2017). Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum. Sci Rep.
Citación estilo ChicagoPersson, Camilla U., Kristoffer von Stedingk, Daniel Bexell, My Merselius, Noémie Braekeveldt, David Gisselsson, Marie Arsenian-Henriksson, Sven Påhlman, y Caroline Wigerup. "Neuroblastoma Patient-derived Xenograft Cells Cultured in Stem-cell Promoting Medium Retain Tumorigenic and Metastatic Capacities but Differentiate in Serum." Sci Rep 2017.
Cita MLAPersson, Camilla U., et al. "Neuroblastoma Patient-derived Xenograft Cells Cultured in Stem-cell Promoting Medium Retain Tumorigenic and Metastatic Capacities but Differentiate in Serum." Sci Rep 2017.